//
Effects of empagliflozin on first and recurrent clinical events in patients with type 2 diabetes and atherosclerotic cardiovascular disease: a secondary analysis of the EMPA-REG OUTCOME trial
Haptoglobin genotype: a determinant of cardiovascular complication risk in type 1 diabetes
Coronary Atherosclerotic Precursors of Acute Coronary Syndromes
Plasma Ionized Calcium and Risk of Cardiovascular Disease: 106 774 Individuals from the Copenhagen General Population Study
Preventive Cardiology as a Subspecialty of Cardiovascular Medicine: JACC Council Perspectives
The contribution of tissue-grouped BMI-associated gene sets to cardiometabolic-disease risk: a Mendelian randomization study
Cellular origin and developmental program of coronary angiogenesis
Potential Mechanisms of In-stent Neointimal Atherosclerotic Plaque Formation